Publication at Second Faculty of Medicine |
2018
Abstract
New technologies are becoming a point of interest in the treatment of very high risk urinary bladder carcinomas as an alternative to radical cystectomy. They are meant to inhance the effectivity of intravesical chemotherapy as an adjuvant treatment after transurethral resection of non-muscle invasice bladder cancer.
Another point is that there is currently long lasting shortage of BCG in the Czech Republic and other countries. We present a review of two technologies using thermic effect and radiofrequency.
We present an overview of available evidence and a vision of the future.